Cite
HARVARD Citation
Torres, A. et al. (2018). Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial. Lancet infectious diseases. 18 (3), pp. 285-295. [Online].